Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

41.94
+1.343.30%
Volume:487.75K
Turnover:20.32M
Market Cap:4.74B
PE:-19.79
High:42.25
Open:42.09
Low:40.91
Close:40.60
52wk High:62.50
52wk Low:18.92
Shares:113.04M
Float Shares:109.98M
Volume Ratio:10.24
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1195
EPS(LYR):-1.0085
ROE:-29.23%
ROA:-20.48%
PB:6.65
PE(LYR):-41.59

Loading ...

Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Proposed Sale Of Securities

Form 144 | VIKING THERAPEUTICS, INC. Director Lawson Macartney proposes to sell 2000 shares, with a total value of approximately $137,334.
Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Oct 28, 2024

Proposed Sale Of Securities

Form 144 | Viking Therapeutics' Officer Greg Zante proposes to sell 131,687 Shares, with a total value of approximately $10.28 Million.
Oct 25, 2024

Proposed Sale Of Securities

Form 144 | Viking Therapeutics' Director Rouan Sarah Kathryn proposes to sell 11,000 shares, with a total value of approximately $889,430.
Oct 25, 2024

Proposed Sale Of Securities

Form 144 | Viking Therapeutics' Director Singleton proposes to sell 16000 shares, with a total value of approximately $1.27 Million.
Oct 23, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 23, 2024

Major Issues Report

Form 8-K - Current report
Oct 18, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2024

Proposed Sale Of Securities

Form144 | Viking Therapeutics' Officer Greg Zante proposes to sell 16,136 shares, with a total value of approximately $922,232.10.